TY -的盟德Lusignan西蒙AU -洛佩兹伯纳尔,杰米•AU - Zambon玛丽亚盟——Akinyemi Oluwafunmi盟——Amirthalingam贾亚特里非盟-安德鲁斯,尼克盟——借,雷盟——Byford,瑞秋盟——Charlett安德烈盟——Dabrera Gavin AU -埃利斯,乔安娜AU -艾略特,亚历克斯·J盟——视野中时,迈克尔AU -费雷拉,Filipa AU - Krajenbrink,其他非盟- Leach,乔纳森盟——林利、以斯拉盟——Liyanage Harshana AU - Okusi,塞西莉亚AU -拉姆齐,玛丽AU -史密斯,吉莉安盟——夏洛克,朱利安AU -托马斯,Nicholas AU - Tripathy, Manasa AU - Williams, John AU - Howsam, Gary AU - Joy, Mark AU - Hobbs, Richard PY - 2020 DA - 2020/4/2 TI -新型冠状病毒(COVID-19)的出现:英国皇家全科医生学院研究和监测中心和公共卫生使用的扩展监测方案JO - JMIR公共卫生监测SP - e18606 VL - 6 IS -2 KW -一般实践KW -医疗记录系统KW -计算机化KW -哨点监测KW -冠状病毒KW - COVID-19 KW - SARS-CoV-2 KW -监测KW -感染KW -大流行KW -作为主题的记录KW -血清学AB -背景:皇家全科医生学院(RCGP)研究和监测中心(RSC)和英格兰公共卫生部(PHE)在流感和其他传染病的监测方面成功合作了50多年，包括之前的三次大流行。随着新型冠状病毒感染(COVID-19)的国际爆发，英国已经制定了一项全国性的控制措施，对疑似接触过COVID-19的人进行检测。与此同时，RCGP RSC的监测工作已扩大到监测COVID-19感染在社区的时间和地理分布，并评估遏制战略的有效性。目的:对无症状人群和呼吸道感染门诊病例进行COVID-19监测，了解COVID-19的传播率和传播模式，评估疫情防控政策的有效性。方法:RCGP RSC，英国500多家全科医生的网络，每周提取假名数据。这种扩大的监测包括五个部分:(1)在医疗记录中记录任何疑似患有或接触过COVID-19的人。电脑化医疗记录供应商在收到请求的一周内创建了新的代码来支持这一点。 (2) Extension of current virological surveillance and testing people with influenza-like illness or lower respiratory tract infections (LRTI)—with the caveat that people suspected to have or who have been exposed to COVID-19 should be referred to the national containment pathway and not seen in primary care. (3) Serology sample collection across all age groups. This will be an extra blood sample taken from people who are attending their general practice for a scheduled blood test. The 100 general practices currently undertaking annual influenza virology surveillance will be involved in the extended virological and serological surveillance. (4) Collecting convalescent serum samples. (5) Data curation. We have the opportunity to escalate the data extraction to twice weekly if needed. Swabs and sera will be analyzed in PHE reference laboratories. Results: General practice clinical system providers have introduced an emergency new set of clinical codes to support COVID-19 surveillance. Additionally, practices participating in current virology surveillance are now taking samples for COVID-19 surveillance from low-risk patients presenting with LRTIs. Within the first 2 weeks of setup of this surveillance, we have identified 3 cases: 1 through the new coding system, the other 2 through the extended virology sampling. Conclusions: We have rapidly converted the established national RCGP RSC influenza surveillance system into one that can test the effectiveness of the COVID-19 containment policy. The extended surveillance has already seen the use of new codes with 3 cases reported. Rapid sharing of this protocol should enable scientific critique and shared learning. International Registered Report Identifier (IRRID): DERR1-10.2196/18606 SN - 2369-2960 UR - https://publichealth.www.mybigtv.com/2020/2/e18606 UR - https://doi.org/10.2196/18606 UR - http://www.ncbi.nlm.nih.gov/pubmed/32240095 DO - 10.2196/18606 ID - info:doi/10.2196/18606 ER -